Saxagliptin overview: special focus on safety and adverse effects

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.1, 2013-01, pp. : 103-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adverse effects of antiretroviral therapy: focus on orofacial effects

By Dios Pedro Diz Scully Crispian

Expert Opinion on Drug Safety, Vol. 1, Iss. 4, 2002-11 ,pp. : 307-317

Informa Healthcare

Access to resources Recommend Favorite

Overview of metformin: special focus on metformin extended release

By Ali Shamsa Fonseca Vivian

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1797-1805

Informa Healthcare

Access to resources Recommend Favorite

Adverse effects of antiretroviral therapy: focus on bone density

By Viganò Alessandra Mora Stefano

Expert Opinion on Drug Safety, Vol. 3, Iss. 3, 2004-05 ,pp. : 199-208

Informa Healthcare

Access to resources Recommend Favorite

Exploration of the DPP-4 inhibitors with a focus on saxagliptin

By Shubrook Jay H Colucci Randall A Schwartz Frank L

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2927-2934

Informa Healthcare

Access to resources Recommend Favorite

Safety and adverse effects associated with GLP-1 analogues

By Stephens Jeffrey W Bain Stephen C

Expert Opinion on Drug Safety, Vol. 6, Iss. 4, 2007-07 ,pp. : 417-422

Informa Healthcare

Access to resources Recommend Favorite